CLOV · Clover Health Investments, Corp
$4.32
+1.52% last session
End-of-day data · updated 2026-07-28
Market cap
$2B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
42.7
Dividend yield
—
Beta
2.42
Avg volume
8M
Employees
1K
2D change
—
5D change
-6.15%
10D change
-7.58%
30D change
-21.07%
60D change
7.29%
MTD change
-20.78%
YTD change
81.70%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CLOV
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-21
Latest call per bank · past 12 months
UBS
Neutral$4.75
+10.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-21 | Canaccord Genuity | Maintains | Buy | $4.20 → $5.50 |
| 2026-06-11 | UBS | Maintains | Neutral | $2.75 → $4.75 |
| 2026-06-04 | Canaccord Genuity | Maintains | Buy | $3.20 → $4.20 |
| 2026-03-20 | Canaccord Genuity | Maintains | Buy | $3.70 → $3.20 |
| 2026-03-05 | Leerink Partners | Maintains | Market Perform | $3.00 → $2.50 |
| 2026-01-20 | Canaccord Genuity | Maintains | Buy | $3.70 |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy | $4.10 → $3.70 |
| 2025-08-07 | Canaccord Genuity | Maintains | Buy | $4.50 → $4.10 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 44 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 3.0% below the 50-day MA ($4.47).
- Price vs 200-day MA: Trading 47.0% above the 200-day MA ($2.95).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.08) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($1.70) and high ($5.41).
CLOV Price Chart
Loading chart for CLOV…
Fundamentals
About Clover Health Investments, Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$379B 28.2% YTD
CVS
CVS Health Corporation
$137B 38.1% YTD
ELV
Elevance Health, Inc.
$82B 9.0% YTD
CI
The Cigna Group
$77B 6.9% YTD
CNC
Centene Corporation
$32B 55.7% YTD
MOH
Molina Healthcare Inc
$10B 14.9% YTD
OSCR
Oscar Health, Inc.
$9B 97.2% YTD
ALHC
Alignment Healthcare, Inc.
$4B -5.5% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.